Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 19, 2026, titled "Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Binimetinib Tablets, 45 mg".
Alembic Pharmaceuticals Limited Press Release Jun 19 2026
Earlier from Alembic Pharmaceuticals
- Alembic Pharmaceuticals Limited Press Release Jun 12 2026
- Alembic Pharmaceuticals Limited Press Release Jun 11 2026
- Press Release Jun 05 2026
- Press Release May 22 2026